Myocardial protection of early extracorporeal membrane oxygenation (ECMO) support for acute myocardial infarction with cardiogenic shock in pigs

Gang-jie Zhu,Li-na Sun,Xing-hai Li,Ning-fu Wang,Hong-hai Wu,Chen-xing Yuan,Qiao-qiao Li,Peng Xu,Ya-qi Ren,Bao-gen Mao
DOI: https://doi.org/10.1007/s00380-014-0564-x
2014-01-01
Heart and Vessels
Abstract:The aim of this study was to explore myocardial protection of early extracorporeal membrane oxygenation (ECMO) support for acute myocardial infarction with cardiogenic shock in pigs. 24 male pigs (34.6 ± 1.3 kg) were randomly divided into three groups—control group, drug therapy group, and ECMO group. Myocardial infarction model was created in drug therapy group and ECMO group by ligating coronary artery. When cardiogenic shock occurred, drugs were given in drug therapy group and ECMO began to work in ECMO group. The pigs were killed 24 h after cardiogenic shock. Compared with in drug therapy group, left ventricular end-diastolic pressure in ECMO group decreased significantly 6 h after ligation ( P < 0.05). At the end of the experiments, LV − d p /d t among three groups was significantly different, drug therapy group < ECMO group < control group. There was no difference in LV + d p /d t between drug therapy group and ECMO group. Compared with drug group, myocardial infarct size of ECMO group did not reduce significantly, but myocardial enzyme and troponin-I decreased significantly. Compared with drug therapy, ECMO improves left ventricular diastolic function, and may improve systolic function. ECMO cannot reduce myocardial infarct size without revascularization, but may have positive effects on ischemic areas by avoiding further injuring.
What problem does this paper attempt to address?